Almirall, Etherna Partner to Develop mRNA-based Therapies in Medical Dermatology
Almirall, S.A. (ALM) and etherna are teaming up to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The alliance combines and leverages etherna’s proprietary mRNA capabilities and lipid nanoparticle (LNP) formulations with Almirall’s medical dermatology expertise to accelerate discovery of novel treatment options. Etherna and Almirall will work collaboratively on the research […]
Better Together: Tapinarof Cream, 1% Plus Biologics Show Promise in Psoriasis
More than half of adult psoriasis patients on biologics hit the National Psoriasis Foundation treat-to-target goal of 1% body surface area (BSA) or less involvement within three months of adding Tapinarof cream, 1% (Vtama, Dermavant).
Meet the 2023 NEA Grant Winners
The National Eczema Association (NEA) announced the recipients for its 2023 research grants. This is the 20th anniversary of NEA’s grant program. So far, the NEA has invested nearly $4 million since its first grant was awarded in 2004. The 2023 research grantees include: The Champion Research Grant encourages researchers to continue research on emerging or ongoing challenges in eczema […]